Study of the Value of Maternal-fetal Transfers and Their Complexity of Their Implementation
NCT ID: NCT06480916
Last Updated: 2024-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2024-04-01
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When maternal-fetal transfer (MFT) is requested, numerous calls are made to private ambulance services, and in the end, many emergency rapid response units (SMUR) are called out, requiring a major human, logistical and time investment for a questionable benefit to the patient. Tensions in terms of logistics (lack of ambulance, SMUR) and human resources (lack of personnel) can, conversely, compromise good care of the parturient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Maternal-fetal transfers
Prospective and consecutive inclusion of all maternal-fetal transfers during the study period. The teams at the sending and receiving maternity units will complete study-related questionnaires to describe the conditions of the transfer and the outcome of the pregnancy. The study in no way alters the way parturients are cared for.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years of age
* Requested for maternal-fetal transfer (finally performed, or not)
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional Metz-Thionville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laetitia HONORE-ROUGE, MD
Role: PRINCIPAL_INVESTIGATOR
CHR Metz Thionville Hopital Femme Mère Enfant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Maillot
Briey, , France
Maternité CH Léon Bourgeois
Châlons-en-Champagne, , France
CHR Metz Thionville Hopital Femme Mère Enfant
Metz, , France
Maternité - Hôpital Maurice Camuset
Romilly-sur-Seine, , France
Clinique Saint Nabor
Saint-Avold, , France
Matérnité Saint Dizier
Saint-Dizier, , France
CHR Metz-Thionville Hopital Bel Air
Thionville, , France
Hopital Saint Nicolas
Verdun, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Arpiné EL NAR
Role: primary
Arpiné EL NAR
Role: primary
Arpiné EL NAR, PhD
Role: primary
Arpiné EL NAR
Role: primary
Arpiné EL NAR
Role: primary
Arpiné EL NAR
Role: primary
Arpiné EL NAR
Role: primary
Arpiné EL NAR
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-04Obs-CHRMT
Identifier Type: -
Identifier Source: org_study_id